NCT05954611View on ClinicalTrials.gov

The Study of Single Dose Administration of GR2002 Injection in Chinese Health Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 16, 2023

Primary Completion Date

January 2, 2024

Study Completion Date

January 2, 2024

Conditions
Asthma
Interventions
BIOLOGICAL

GR2002 injection

one single dose of GR2002 injection

BIOLOGICAL

Placebo

one single dose of placebo

Trial Locations (1)

Unknown

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Genrix (Shanghai) Biopharmaceutical Co., Ltd.

INDUSTRY

NCT05954611 - The Study of Single Dose Administration of GR2002 Injection in Chinese Health Volunteers | Biotech Hunter | Biotech Hunter